F E Preston

10.3k total citations · 1 hit paper
170 papers, 7.6k citations indexed

About

F E Preston is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, F E Preston has authored 170 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Hematology, 30 papers in Cardiology and Cardiovascular Medicine and 28 papers in Genetics. Recurrent topics in F E Preston's work include Blood Coagulation and Thrombosis Mechanisms (67 papers), Hemophilia Treatment and Research (62 papers) and Venous Thromboembolism Diagnosis and Management (23 papers). F E Preston is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (67 papers), Hemophilia Treatment and Research (62 papers) and Venous Thromboembolism Diagnosis and Management (23 papers). F E Preston collaborates with scholars based in United Kingdom, Netherlands and Italy. F E Preston's co-authors include M. Greaves, Michael Makris, Steve Kitchen, Frits R. Rosendaal, R G Malía, Isobel D. Walker, Steve Kitchen, Ian Jennings, D. R. Triger and P. Cooper and has published in prestigious journals such as The Lancet, Blood and Annals of Surgery.

In The Last Decade

F E Preston

164 papers receiving 7.1k citations

Hit Papers

Geographic Distribution o... 1998 2026 2007 2016 1998 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
F E Preston 4.3k 1.8k 1.8k 1.2k 969 170 7.6k
Michael Makris 6.4k 1.5× 2.2k 1.2× 2.2k 1.2× 882 0.8× 727 0.8× 242 9.8k
Howard A. Liebman 3.4k 0.8× 4.2k 2.3× 2.7k 1.5× 911 0.8× 588 0.6× 157 9.9k
Thomas Lecompte 3.2k 0.7× 1.8k 1.0× 1.7k 1.0× 532 0.5× 253 0.3× 239 6.6k
Joan Carles Reverter 2.1k 0.5× 686 0.4× 1.0k 0.6× 989 0.8× 764 0.8× 222 6.3k
Craig M. Kessler 6.7k 1.6× 2.4k 1.3× 2.1k 1.2× 906 0.8× 303 0.3× 294 11.6k
I. Scharrer 6.0k 1.4× 1.5k 0.8× 1.3k 0.7× 574 0.5× 263 0.3× 180 10.1k
Ravi Sarode 2.9k 0.7× 1.6k 0.9× 2.2k 1.3× 859 0.7× 248 0.3× 221 8.3k
Philippe de Moerloose 3.2k 0.8× 1.7k 0.9× 1.2k 0.7× 691 0.6× 255 0.3× 220 8.2k
J W ten Cate 2.2k 0.5× 1.9k 1.0× 1.4k 0.8× 988 0.8× 141 0.1× 168 6.3k
Michael Spannagl 1.7k 0.4× 1.9k 1.0× 1.6k 0.9× 814 0.7× 274 0.3× 130 5.8k

Countries citing papers authored by F E Preston

Since Specialization
Citations

This map shows the geographic impact of F E Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F E Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F E Preston more than expected).

Fields of papers citing papers by F E Preston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F E Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F E Preston. The network helps show where F E Preston may publish in the future.

Co-authorship network of co-authors of F E Preston

This figure shows the co-authorship network connecting the top 25 collaborators of F E Preston. A scholar is included among the top collaborators of F E Preston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F E Preston. F E Preston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murray, Ellen, D A Fitzmaurice, Dianne Kitchen, et al.. (2005). An evaluation of four methods of external quality assurance (EQA) for patient self-management of oral anticoagulation. British Journal of Haematology. 129. 12–12. 1 indexed citations
2.
VOSSEN, C.Y., J. Conard, J. Fontcuberta, et al.. (2005). Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). Journal of Thrombosis and Haemostasis. 3(3). 459–464. 142 indexed citations
3.
Jennings, Ian, Ian Mackie, Jef Arnout, & F E Preston. (2004). Lupus anticoagulant testing using plasma spiked with monoclonal antibodies: performance in the UK NEQAS proficiency testing programme. Journal of Thrombosis and Haemostasis. 2(12). 2178–2184. 27 indexed citations
4.
Jennings, Ian, Steve Kitchen, Tim Woods, & F E Preston. (2003). Problems relating to the laboratory diagnosis of factor XIII deficiency: a UK NEQAS study. Journal of Thrombosis and Haemostasis. 1(12). 2603–2608. 52 indexed citations
5.
Kitchen, Steve, Ian J. Cartwright, Tim Woods, Ian Jennings, & F E Preston. (1999). Lipid composition of seven APTT reagents in relation to heparin sensitivity. British Journal of Haematology. 106(3). 801–808. 36 indexed citations
6.
Preston, F E, Frits R. Rosendaal, Isobel D. Walker, et al.. (1997). Increased Fetal Loss in Women With Heritable Thrombophilia. Obstetrical & Gynecological Survey. 52(3). 155–156. 40 indexed citations
7.
Chuansumrit, Ampaiwan, Anne Goodeve, Werasak Sasanakul, et al.. (1995). DNA polymorphisms for carrier detection of hemophilia in Thailand.. PubMed. 26 Suppl 1. 201–6. 1 indexed citations
8.
Bardhan, Karna Dev, et al.. (1993). Reduced tissue type plasminogen activator activity of the gastroduodenal mucosa in peptic ulcer disease.. Gut. 34(10). 1310–1314. 12 indexed citations
9.
Makris, Michael, et al.. (1993). Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients. Blood. 81(7). 1898–1902. 51 indexed citations
10.
Makris, Michael & F E Preston. (1993). Chronic hepatitis in haemophilia. Blood Reviews. 7(4). 243–250. 19 indexed citations
11.
Mannucci, Pier Mannuccio, K. Schimpf, Takaya Abe, et al.. (1992). Low risk of viral infection after administration of vapor‐heated factor VIII concentrate. Transfusion. 32(2). 134–138. 41 indexed citations
12.
Wilde, J, Steve Kitchen, S. E. Kinsey, M. Greaves, & F E Preston. (1989). Plasma D‐dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states. British Journal of Haematology. 71(1). 65–70. 93 indexed citations
13.
Dolan, G., M. Greaves, P. Cooper, & F E Preston. (1988). Thrombovascular disease and familial plasminogen deficiency: a report of three kindreds. British Journal of Haematology. 70(4). 417–421. 25 indexed citations
14.
Greaves, M., et al.. (1986). Orbital plasmacytoma in established myeloma-a report of two cases. Clinical & Laboratory Haematology. 8(2). 155–159. 5 indexed citations
15.
Carne, C A, S. G. Elkington, F E Preston, et al.. (1985). ACUTE ENCEPHALOPATHY COINCIDENT WITH SEROCONVERSION FOR ANTI-HTLV-III. The Lancet. 326(8466). 1206–1208. 198 indexed citations
16.
Preston, F E, Robert J. Sokol, J S Lilleyman, D.A. Winfield, & E. K. Blackburn. (1978). Cellular hyperviscosity as a cause of neurological symptoms in leukaemia.. BMJ. 1(6111). 476–478. 50 indexed citations
17.
Preston, F E, et al.. (1977). The Factor VIII Molecule in Acquired Von Willebrand’s Disease. Thrombosis and Haemostasis. 1 indexed citations
18.
Sworn, M J, et al.. (1973). Disseminated intravascular coagulation with thymoma-associated Cushing's syndrome.. BMJ. 2(5862). 343–344. 4 indexed citations
19.
Preston, F E & I. Ralph Edwards. (1973). Postpartum purpura fulminans: successful management with streptokinase.. BMJ. 3(5875). 329–330. 7 indexed citations
20.
Preston, F E & A. Milford Ward. (1972). Acute renal failure in myelomatosis from intravascular coagulation.. BMJ. 1(5800). 604–605. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026